If you cannot see this email please follow this link.
Newsletter Regulatory Affairs
Your monthly regulatory affairs update
{Anrede},

Welcome to the April 2025 edition of our Regulatory Affairs Newsletter.

In this issue, we provide you with a comprehensive overview of the key regulatory developments from the past few weeks. Additionally, you receive a summary of the online course "JCA Dossiers & Joint Clinical Assessments", which took place on 24 March 2025.

If you have any requests or suggestions, please feel free to contact us. We look forward to hearing from you!
Editorial
News from ICH
News from European Commission
News from HMA
News from EMA
News from BfArM and PEI
Veterinary news
Monthly reports
Editorial

Author: Dr Henriette Wolf-Klein, FORUM Institut für Management GmbH

On 24 March 2025, the online course "JCA Dossiers & Joint Clinical Assessments" took place.

Anne Willemsen (Co-Chair of the JCA subgroup under the HTA Coordination Group) informed that two JCA procedures have already started (one ATMP and one in the indication of oncology). The procedures are generally planned without clock stops, but CHMP decisions will be awaited.
... Read more


News from ICH
ICH M11 on technical specification (CLINICAL ELECTRONIC STRUCTURED HARMONISED PROTOCOL (CeSHarP)) has reached an Updated Step 2b and can be commented on by 22 April 2025.
Details


News from European Commission
The EU Commission released the open-source HealthData@EU Central Platform.
Details


News from HMA
EMA and the Heads of Medicines Agencies (HMA) are warning the public about the dangers of unregulated advanced therapy medicinal products (ATMPs) offered to patients in the European Union.
Details

In case you are interested in a general and broad overview of topics that concern ATMPs you are welcome to participate in the seminar "All about ATMP" on 23-24 September 2025.
Details


More specific information amongst others on ATMPs are addressed in the German-speaking seminar "Human-Gewebe/Gewebezubereitungen zur Anwendung am Menschen" on 13 November 2025.
Details



News from EMA
EMA published a draft reflection paper on linking to electronic product information (ePI) from EU medicine packages. The draft can be commented on by 30 June 2025.
Details


EMA published a new draft guideline on the quality aspects of mRNA vaccines. The draft guideline can be commented on by 30 September 2025.
Details


On 4 April EMA informed on an updated timeline regarding human variations electronic Application Forms (eAF).
Details

eSubmission requirements for APIs are discussed during the German-speaking seminar "APIs in Regulatory Affairs" on 22-23 September 2025.
Details



PharmaFORUM Webcast International - More information >>


News from BfArM and PEI
German BfArM informs on the EU Regulation on labelling requirements with regard to "fluorinated greenhouse gases".
Details

This German speaking course focusses on this topic as well: F-Gase: Die Folgen der neuen EU-Verordnung.
Details



Bulletin on Drug Safety - Issue 1/2025 has been published by BfArM and PEI.
Details


Veterinary news
EMA published a first report on EU-wide sales and use of antimicrobials in animals.
Details

The FORUM Institute offers a seminar "Pharmacovigilance in Veterinary Medicines" in June in German.
Details



Monthly reports
PRAC
Details


CHMP
Details


CMDh
Details


CVMP
Details



Kind regards,

Jean-Marie Bayhurst
Your contact for
Regulatory Affairs (Human)
+49 6221 500-685
Dr C. Michaela Gottwald
Your contact for
Regulatory Affairs (Veterinary)
+49 6221 500-610
Dr Birgit Wessels
Your contact for
CMC
+49 6221 500-652


Verena Planitz
Your contact for
Global Regulatory Affairs
+49 6221 500-655

TO UNSUBSCRIBE:
If you do not want to receive this information in future, you can unsubscribe here!
FORUM · Institut für Management GmbH · Vangerowstr. 18 · 69115 Heidelberg · Germany
Fon +49 6221 500-500 · Fax +49 6221 500-555 · service@forum-institut.de · www.forum-institut.com
Copyright 2025 FORUM · Institut für Management GmbH
Imprint, privacy policy, terms and conditions

We guarantee the highest quality with ISO 9001 and ISO 21001 certifications.
Nachhaltigkeit